ArticlebioRxiv : the preprint server for biology2025

Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses.

Jonathan Munro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.